REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,904 | +24.5% | 10,076 | +20.3% | 0.01% | +37.5% |
| Q2 2023 | $224,031 | +52.4% | 8,375 | +23.4% | 0.01% | +33.3% |
| Q1 2023 | $147,028 | -8.4% | 6,788 | +16.3% | 0.01% | 0.0% |
| Q4 2022 | $160,428 | +39.5% | 5,838 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $115,000 | +27.8% | 5,838 | +25.4% | 0.01% | +25.0% |
| Q2 2022 | $90,000 | -24.4% | 4,657 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $119,000 | +1.7% | 4,657 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $117,000 | -8.6% | 4,657 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $128,000 | -13.5% | 4,657 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $148,000 | -6.9% | 4,657 | +34.1% | 0.01% | -16.7% |
| Q1 2021 | $159,000 | +22.3% | 3,474 | +5.7% | 0.01% | 0.0% |
| Q4 2020 | $130,000 | +14.0% | 3,287 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $114,000 | +192.3% | 3,287 | +169.4% | 0.01% | +150.0% |
| Q2 2020 | $39,000 | +44.4% | 1,220 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $27,000 | – | 1,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |